The global personalized therapy biosimulation market size reached USD 1,061.7 Million in 2020 and is expected to register a revenue CAGR of 14.6% during the forecast period, according to the latest analysis by Emergen Research. Rising incidence of drug relapse and drug resistance cases and increasing application of quantitative system pharmacology in drug development processes are some key factors driving global personalized therapy biosimulation market revenue growth.
The analysis provides accurate growth pattern estimates and looks at the factors influencing market growth in the global Personalized Therapy Biosimulation market. The report's primary focus is on the key market constituents, including market drivers, restraints, opportunities, threats, risks, restrictions, and other factors. The research includes comprehensive studies of the company profiles, product portfolio, and corporate expansion strategies, in addition to a complete investigation of the competition landscape.
Drug development is a lengthy, complex, multifaceted, and costly process, with high failure rates and fewer drugs receiving U.S. Food & Drug Administration (FDA) approval. The low success rate, increasing R&D expenditure, and rising incidence of drug resistance in cancer, epilepsy, and tuberculosis, among others, are some factors driving the rising need for incorporating biosimulation techniques for the development of new generations of drugs. The majority of patients show resistance to novel targeted drugs or classical chemotherapeutic agents and do not respond to standard cancer treatment options such as chemotherapy and radiation therapy, thereby leading to a higher cancer recurrence rate. In recent years, the majority of biopharmaceutical companies have been employing modeling and simulation techniques in the drug discovery and development process, ranging from target identification and validation through the analysis of preclinical data to the analysis of phase I, II, and III clinical trial data for optimizing doses for safety and efficacy. Hence, the majority of pharmaceutical and biotechnology companies are incorporating biosimulation in clinical studies to determine a patient’s Therapy Response Index (TRI) to understand whether a patient will respond to standard care treatment, identify optimal therapies, and thereby improve clinical efficacy, avoid ineffective treatment, and improve the overall survival rate of patients. This is expected to drive the growth of the market to a significant extent going forward.
To receive a PDF sample of the report, visit @
https://www.emergenresearch.com/request-sample/785Global Personalized Therapy Biosimulation Market Highlights:
Regional demand estimation and forecast
Product Mix Matrix
R&D Analysis
Cost-Benefit Analysis
Pre-commodity pricing volatility
Supply chain optimization analysis
Technological updates analysis
Raw Material Sourcing Strategy
Competitive Analysis
Mergers & Acquisitions
Location Quotients Analysis
Carbon Footprint Analysis
Patent Analysis
Vendor Management
Competitive Landscape:
The latest study provides an insightful analysis of the broad competitive landscape of the global Personalized Therapy Biosimulation market, emphasizing the key market rivals and their company profiles. A wide array of strategic initiatives, such as new business deals, mergers & acquisitions, collaborations, joint ventures, technological upgradation, and recent product launches, undertaken by these companies has been discussed in the report. The report analyzes various elements of the market’s competitive scenario, such as the regulatory standards and policies implemented across the industry over recent years. Our team of experts has leveraged several powerful analytical tools, such as Porter’s Five Forces analysis and SWOT analysis, to deliver a comprehensive overview of the global Personalized Therapy Biosimulation market and pinpoint the fundamental growth trends.
Key Companies Profiled in the Report are:
Cellworks Group Inc., Certara USA Inc., Simulation Plus Inc., Schrodinger Inc., In Silico Biosciences Inc., Genedata AG, Physiomics plc, Insilico Biotechology AG, Chemical Computing Group ULC (CCG), and Evidera Inc
Key Parameters Analyzed in This Section:
Company Profiles
Gross Revenue
Profit margins
Product sales trends
Product pricing
Industry Analysis
Sales & distribution channels
Regional Segmentation:
North America
Latin America
Europe
Middle East & Africa
Asia Pacific
Key Points Covered in This Section:
Regional contribution
Estimated revenue generation
Vital data and information about the consumption rate in all the leading regional segments
An expected rise in market share
Forecast growth in the overall consumption rate
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends @
https://www.emergenresearch.com/industry-report/personalized-therapy-biosimulation-marketSome Key Highlights from the Report
Software segment is expected to account for largest revenue share over the forecast period due to increasing adoption of biosimulation software by pharmaceutical and biotechnology companies, Contract Research Organizations, regulatory agencies, and academic and research institutes to accelerate drug development process and rapid technological advancements and up-gradation in the software.
Oncology segment revenue is expected to expand at a rapid CAGR over the forecast period owing to rising prevalence of cancer, increasing adoption of personalized medicine approach for cancer treatment and increasing use of biosimulation platform to predict individual response to cancer therapeutics and minimize drug resistance among cancer patients.
Drug discovery segment revenue is expected to register a significantly robust CAGR over the forecast period owing to increasing use of biosimulation technique in drug discovery process ranging from target validation, lead identification, lead optimization, to product characterization.
Pharmaceutical & biotechnology companies segment is expected to account for largest revenue share over the forecast period owing to increasing adoption of computer modelling approach for development of safe and effective medication, streamlining clinical trial process, reducing costs involved in production of new drugs, improving selection of targeted population, and developing advanced therapeutics for cancer.
North America is expected to account largest revenue share over the forecast period due to increasing demand for biomedical simulations, increasing adoption of personalized therapy approach, increasing number of clinical trial process, and increasing implementation of computational modelling in clinical trial process.
Market Overview:
The report bifurcates the Personalized Therapy Biosimulation market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.
Segments Covered in this report are:
Product Outlook (Revenue, USD Billion; 2018–2028)
Software
Services
Therapeutic Area Outlook (Revenue, USD Billion; 2018–2028)
Oncology
Others
Application Outlook (Revenue, USD Billion; 2018–2028)
Drug Development
Drug Discovery
Others
To seek a discount on this report, visit @
https://www.emergenresearch.com/request-discount/785Additional information offered by the report:
Along with a complete overview of the global Cobots market, the report provides detailed scrutiny of the diverse market trends observed on both regional and global levels.
The report elaborates on the global Cobots market size and share governed by the major geographies.
It performs a precise market growth forecast analysis, cost analysis, and a study of the micro- and macro-economic indicators.
It further presents a detailed description of the company profiles of the key market contenders.
Request Customization as per your specific requirement @
https://www.emergenresearch.com/request-for-customization/785Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.
Latest Published Reports by Emergen Research:
human microbiome modulators market
https://www.emergenresearch.com/industry-report/human-microbiome-modulators-marketwater storage systems market
https://www.emergenresearch.com/industry-report/water-storage-systems-marketagricultural lubricants market
https://www.emergenresearch.com/industry-report/agricultural-lubricants-marketmammography workstations market
https://www.emergenresearch.com/industry-report/mammography-workstations-marketcooling fabrics market
https://www.emergenresearch.com/industry-report/cooling-fabrics-marketcast elastomers market
https://www.emergenresearch.com/industry-report/cast-elastomers-marketmembrane bioreactor market
https://www.emergenresearch.com/industry-report/membrane-bioreactor-marketquantum computing for enterprise market
https://www.emergenresearch.com/industry-report/quantum-computing-for-enterprise-marketiot chip market
https://www.emergenresearch.com/industry-report/iot-chip-marketinternet of things insurance market
https://www.emergenresearch.com/industry-report/internet-of-things-insurance-marketAbout Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web:
www.emergenresearch.comDirect Line: +1 (604) 757-9756
E-mail:
sales@emergenresearch.comVisit for More Insights:
https://www.emergenresearch.com/insightsExplore Our Custom Intelligence services | Growth Consulting Services
Latest Report: Medical Vacuum System Market, Stereotactic Surgery Devices Market
Trending Title: Veterinary Care Market, Veterinary Dental Equipment Market
